DMS Pharmaceutical Group Inc
DMS Pharmaceutical Group Inc received $188.1M in federal prime contract obligations in the 12 months ending Oct 5, 2026, down 36.9% from $298.3M the year before, and $1.3B since FY2022. Its largest customer is the Department of Defense.
Contractor details
- Unique Entity ID (UEI)
- PX72BSBQTKJ3
- CAGE code
- 1UNB0
- Headquarters
- Park Ridge, IL
- Business size
- Small Business
- Socioeconomic status
- WOSB
As recorded on this UEI's most recent prime contract action in USAspending.gov. Confirm current registration and certifications in SAM.gov.
Obligations by fiscal year
Net prime contract obligations by federal fiscal year.
Markets where it ranks top 10
Agency and NAICS markets where this UEI is one of the ten largest primes in the latest 12 months.
Top agencies
Funding agencies ranked by obligations since FY2022.
| Funding agency | Latest 12 mo | Since FY2022 |
|---|---|---|
| Department of Defense | $188.1M | $1.3B |
| Department of Veterans Affairs | $0 | $193K |
Top NAICS codes
Industry codes agencies recorded on this contractor's awards, since FY2022.
| NAICS | Industry | Latest 12 mo | Since FY2022 |
|---|---|---|---|
| 424210 | Drugs and Druggists' Sundries Merchant Wholesalers | $175.8M | $1.1B |
| 325411 | Medicinal and Botanical Manufacturing | $12.5M | $146.7M |
| 325412 | Pharmaceutical Preparation Manufacturing | −$299K | $10.3M |
| 423450 | Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers | $81K | $299K |
| 456199 | All Other Health and Personal Care Retailers | $0 | $27K |
| 325414 | Biological Product (except Diagnostic) Manufacturing | −$1K | $20K |
What it sells
Product and service codes (PSC) on this contractor's awards, since FY2022.
| PSC | Description | Since FY2022 |
|---|---|---|
| 6505 | Drugs and Biologicals | $1.2B |
| 6515 | Medical and Surgical Instruments, Equipment, and Supplies | $42.7M |
| 6508 | Medicated Cosmetics and Toiletries | $5K |
Recent awards
This contractor's newest prime contract awards, most recent first.
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| SPE2DR26FDAQ0 | Department of Defense 4572325213!GAMIFANT 50 MG/10 ML VIAL 10ML | $306K | Jul 6, 2026 |
| SPE2DR26FFDM6 | Department of Defense 4572329198!KEYTRUDA 100 MG/4 ML VIAL 4ML | $209K | Jul 6, 2026 |
| SPE2DR26FQRF3 | Department of Defense 4572329199!KEYTRUDA 100 MG/4 ML VIAL 4ML | $157K | Jul 6, 2026 |
| SPE2DR26FQKD3 | Department of Defense 4572340058!YF-VAX 1 DOSE VIALS | $63K | Jul 6, 2026 |
| SPE2DR26FSCW1 | Department of Defense 4572337040!ICLUSIG 45 MG TABLET 30S | $59K | Jul 6, 2026 |
| SPE2DR26FDAP8 | Department of Defense 4572329189!KEYTRUDA 100 MG/4 ML VIAL 4ML | $44K | Jul 6, 2026 |
| SPE2DU26FENAR | Department of Defense 4572415392!PHARMACEUTICAL PV DIV - FSB | $41K | Jul 6, 2026 |
| SPE2DR26FSCW0 | Department of Defense 4572329186!ADCETRIS 50 MG VIALS | $36K | Jul 6, 2026 |
Prime contracts (award types A–D) from USAspending.gov through Oct 5, 2026. Subcontracts are not included. Net obligations include deobligations and corrections.
Ready to connect your pursuit work?
GovEagle gives BD directors, capture managers, and proposal teams one AI workspace from pipeline through proposal, with CMMC/FedRAMP Certified compliance built in.